BMO Capital Maintains Outperform on AbbVie, Raises Price Target to $129
BMO Capital analyst Gary Nachman maintains AbbVie (NYSE:ABBV) with a Outperform and raises the price target from $127 to $129.
Earnings Scheduled For April 30, 2021
Companies Reporting Before The Bell
• O2Micro Intl (NASDAQ:OIIM) is estimated to report quarterly earnings at $0.09 per share on revenue of $23.30 million.